Biotechnology for Biofuels / Production of four Neurospora crassa lytic polysaccharide monooxygenases in Pichia pastoris monitored by a fluorimetric

Background: Recent studies demonstrate that enzymes from the glycosyl hydrolase family 61 (GH61) show lytic polysaccharide monooxygenase (PMO) activity. Together with cellobiose dehydrogenase (CDH) an enzymatic system capable of oxidative cellulose cleavage is formed, which increases the efficiency of cellulases and put PMOs at focus of biofuel research. Large amounts of purified PMOs, which are difficult to obtain from the native fungal producers, are needed to study their reaction kinetics, structure and industrial application. In addition, a fast and robust enzymatic assay is necessary to monitor enzyme production and purification. Results: Four pmo genes from Neurospora crassa were expressed in P. pastoris under control of the AOX1 promoter. High yields were obtained for the glycosylated gene products PMO-01867, PMO-02916 and PMO-08760 (>300 mg L-1), whereas the yield of non-glycosylated PMO-03328 was moderate (~45 mg L-1). The production and purification of all four enzymes was specifically followed by a newly developed, fast assay based on a side reaction of PMO: the production of H2O2 in the presence of reductants. While ascorbate is a suitable reductant for homogeneous PMO preparations, fermentation samples require the specific electron donor CDH. Conclusions: P. pastoris is a high performing expression host for N. crassa PMOs. The pmo genes under control of the native signal sequence are correctly processed and active. The novel CDH-based enzyme assay allows fast determination of PMO activity in fermentation samples and is robust against interfering matrix components

Functional expression of a blood tolerant laccase in Pichia pastoris

Background: Basidiomycete high-redox potential laccases (HRPLs) working in human physiological fluids (pH 7.4, 150 mM NaCl) arise great interest in the engineering of 3D-nanobiodevices for biomedical uses. In two previous reports, we described the directed evolution of a HRPL from basidiomycete PM1 strain CECT 2971: i) to be expressed in an active, soluble and stable form in Saccharomyces cerevisiae, and ii) to be active in human blood. In spite of the fact that S. cerevisiae is suited for the directed evolution of HRPLs, the secretion levels obtained in this host are not high enough for further research and exploitation. Thus, the search for an alternative host to over-express the evolved laccases is mandatory. Results: A blood-active laccase (ChU-B mutant) fused to the native/evolved -factor prepro-leader was cloned under the control of two different promoters (PAOX1 and PGAP) and expressed in Pichia pastoris. The most active construct, which contained the PAOX1 and the evolved prepro-leader, was fermented in a 42-L fed-batch bioreactor yielding production levels of 43 mg/L. The recombinant laccase was purified to homogeneity and thoroughly characterized. As happened in S. cerevisiae, the laccase produced by P. pastoris presented an extra N-terminal extension (ETEAEF) generated by an alternative processing of the -factor pro-leader at the Golgi compartment. The laccase mutant secreted by P. pastoris showed the same improved properties acquired after several cycles of directed evolution in S. cerevisiae for blood-tolerance: a characteristic pH-activity profile shifted to the neutral-basic range and a greatly increased resistance against inhibition by halides. Slight biochemical differences between both expression systems were found in glycosylation, thermostability and turnover numbers. Conclusions: The tandem-yeast system based on S. cerevisiae to perform directed evolution and P. pastoris to over-express the evolved laccases constitutes a promising approach for the in vitro evolution and production of these enzymes towards different biocatalytic and bioelectrochemical applications.(VLID)90678

Characterization of three pyranose dehydrogenase isoforms from the litter-decomposing basidiomycete Leucoagaricus meleagris (syn. Agaricus meleagris)

Nicht verfügbarMultigenicity is commonly found in fungal enzyme systems, with the purpose of functional compensation upon deficiency of one of its members or leading to enzyme isoforms with new functionalities through gene diversification. Three genes of the flavin-dependent glucosemethanolcholine (GMC) oxidoreductase pyranose dehydrogenase (AmPDH) were previously identified in the litter-degrading fungus Agaricus (Leucoagaricus) meleagris, of which only AmPDH1 was successfully expressed and characterized. The aim of this work was to study the biophysical and biochemical properties of AmPDH2 and AmPDH3 and compare them with those of AmPDH1. AmPDH1, AmPDH2 and AmPDH3 showed negligible oxygen reactivity and possess a covalently tethered FAD cofactor. All three isoforms can oxidise a range of different monosaccarides and oligosaccharides including glucose, mannose, galactose and xylose, which are the main constituent sugars of cellulose and hemicelluloses, and judging from the apparent steady-state kinetics determined for these sugars, the three isoforms do not show significant differences pertaining to their reaction with sugar substrates. They oxidize glucose both at C2 and C3 and upon prolonged reaction C2 and C3 double-oxidized glucose is obtained, confirming that the A. meleagris genes pdh2 (AY753308.1) and pdh3 (DQ117577.1) indeed encode CAZy class AA3_2 pyranose dehydrogenases. While reactivity with electron donor substrates was comparable for the three AmPDH isoforms, their kinetic properties differed significantly for the model electron acceptor substrates tested, a radical (the 2,2′-azino-bis[3-ethylbenzothiazoline-6-sulphonic acid] cation radical), a quinone (benzoquinone) and a complexed iron ion (the ferricenium ion). Thus, a possible explanation for this PDH multiplicity in A. meleagris could be that different isoforms react preferentially with structurally different electron acceptors in vivo.(VLID)192910

Lacasa de alto potencial redox funcional en sangre mediante evolución dirigida método de obtención y sus aplicaciones

La presente invención describe una lacasa de alto potencial redox obtenida mediante evolución molecular dirigida que es activa en condiciones electrofisiológicas, que resiste elevadas concentraciones de haluros, que tiene una actividad significativa a pHs neutros/alcalinos y que es activa en sangre y plasma humano. La presente invención se refiere a la secuencia aminoacídica de dicha lacasa, a la secuencia nucleotídica que codifica para dicha lacasa y células que permiten su obtención. La lacasa de la invención presenta aplicaciones en diversos sectores: nano-biotecnología, biomedicina, procesos de biorremediación, industria papelera y química fina.Peer reviewedConsejop Superior de Investigaciones CientíficasB1 Patente sin examen previ

Lacasa de alto potencial redox funcional en sangre mediante evolución dirigida método de obtención y sus aplicaciones

La presente invención describe una lacasa de alto potencial redox obtenida mediante evolución molecular dirigida que es activa en condiciones electrofisiológicas, que resiste elevadas concentraciones de haluros, que tiene una actividad significativa a pHs neutros/alcalinos y que es activa en sangre y plasma humano. La presente invención se refiere a la secuencia aminoacídica de dicha lacasa, a la secuencia nucleotídica que codifica para dicha lacasa y células que permiten su obtención. La lacasa de la invención presenta aplicaciones en diversos sectores: nano-biotecnología, biomedicina, procesos de biorremediación, industria papelera y química fina.Peer reviewedConsejop Superior de Investigaciones CientíficasA1 Solicitud de patente con informe sobre el estado de la técnic

Simple and efficient expression of Agaricus meleagris pyranose dehydrogenase in Pichia pastoris

Pyranose dehydrogenase (PDH) is a fungal flavin-dependent sugar oxidoreductase that is highly interesting for applications in organic synthesis or electrochemistry. The low expression levels of the filamentous fungus Agaricus meleagris as well as the demand for engineered PDH make heterologous expression necessary. Recently, Aspergillus species were described to efficiently secrete recombinant PDH. Here, we evaluate recombinant protein production with expression hosts more suitable for genetic engineering. Expression in Escherichia coli resulted in no soluble or active PDH. Heterologous expression in the methylotrophic yeast Pichia pastoris was investigated using two different signal sequences as well as a codon-optimized sequence. A 96-well plate activity screening for transformants of all constructs was established and the best expressing clone was used for large-scale production in 50-L scale, which gave a volumetric yield of 223 mg L−1 PDH or 1,330 U L−1 d−1 in space–time yield. Purification yielded 13.4 g of pure enzyme representing 95.8% of the initial activity. The hyperglycosylated recombinant enzyme had a 20% lower specific activity than the native enzyme; however, the kinetic properties were essentially identical. This study demonstrates the successful expression of PDH in the eukaryotic host organism P. pastoris paving the way for protein engineering. Additionally, the feasibility of large-scale production of the enzyme with this expression system together with a simplified purification scheme for easy high-yield purification is shown

Lacasa de alto potencial redox funcional en sangre mediante evolución dirigida método de obtención y sus aplicaciones

La presente invención describe una lacasa de alto potencial redox obtenida mediante evolución molecular dirigida que es activa en condiciones electrofisiológicas, que resiste elevadas concentraciones de haluros, que tiene una actividad significativa a pHs neutros/alcalinos y que es activa en sangre y plasma humano. La presente invención se refiere a la secuencia aminoacídica de dicha lacasa, a la secuencia nucleotídica que codifica para dicha lacasa y células que permiten su obtención. La lacasa de la invención presenta aplicaciones en diversos sectores: nano-biotecnología, biomedicina, procesos de biorremediación, industria papelera y química fina.Peer reviewedConsejop Superior de Investigaciones CientíficasA1 Solicitud de patente con informe sobre el estado de la técnic

Lacasa de alto potencial redox funcional en sangre mediante evolución dirigida método de obtención y sus aplicaciones

La presente invención describe una lacasa de alto potencial redox obtenida mediante evolución molecular dirigida que es activa en condiciones electrofisiológicas, que resiste elevadas concentraciones de haluros, que tiene una actividad significativa a pHs neutros/alcalinos y que es activa en sangre y plasma humano. La presente invención se refiere a la secuencia aminoacídica de dicha lacasa, a la secuencia nucleotídica que codifica para dicha lacasa y células que permiten su obtención. La lacasa de la invención presenta aplicaciones en diversos sectores: nano-biotecnología, biomedicina, procesos de biorremediación, industria papelera y química fina.Peer reviewedConsejop Superior de Investigaciones CientíficasB1 Patente sin examen previ